Background and Purpose-Endovascular therapy has increasingly become the most common treatment for unruptured cerebral aneurysms in the United States. We evaluated a national, multi-hospital database to examine recent utilization trends and compare periprocedural outcomes between clipping and coiling treatments of unruptured aneurysms. Methods-The Premier Perspective database was used to identify patients hospitalized between 2006 to 2011 for unruptured cerebral aneurysm who underwent clipping or coiling therapy. A logistic propensity score was generated for each patient using relevant patient, procedure, and hospital variables, representing the probability of receiving clipping. Covariate balance was assessed using conditional logistic regression. Following propensity score adjustment using 1:1 matching methods, the risk of in-hospital mortality and morbidity was compared between clipping and coiling cohorts. 
F
or patients harboring an unruptured cerebral aneurysm, treatment options vary and may include surgery, endovascular treatment, or no treatment at all. The subsequent risk of subarachnoid hemorrhage after discovery of an unruptured aneurysm is often relatively low, and therefore the risks associated with either surgical or endovascular treatment must be low in order to justify treatment. 1, 2 Treatment strategies for unruptured aneurysms have changed substantially during the past 2 decades, primarily as a result of the increasing role of endovascular therapy with coiling. In light of these evolving changes in clinical practice, it is critical to monitor the impact of these changes on patient treatment trends and clinical outcomes. Previously published large patient database studies have demonstrated that patients who underwent clipping for unruptured aneurysms had worse outcomes compared with patients who underwent coiling. [3] [4] [5] [6] [7] However, these retrospective studies may have been affected by selection bias, because patients were not randomized to clipping or coiling. To address this concern of selection bias, we performed a propensity score analysis of patients treated with clipping or coiling of unruptured aneurysms between 2006 and 2011 to assess for disparities in periprocedural outcomes between these 2 treatment modalities. Recent trends in treatment utilization were also examined.
Methods

Study Population and Design
The Perspective database (Premier Inc, Charlotte, NC) is a voluntary, fee-supported collection of data developed to assess the quality and resource utilization of health care delivery within the United States. 8 As of 2011, the Perspective database consisted of ≈15% of hospitalizations nationwide and represented >600 US hospitals. Detailed information of a patient's hospitalization, including patient demographics, hospital information, diagnoses, procedures, discharge status, and all billed items, are recorded. Time of procedures and administration of billed items, tests, and exams are reported in relation to the day of admission. 
ICD-9-CM (International
Outcome Variables
The primary outcome variables of this study were death during hospitalization, discharge to long-term care (hospice, skilled nursing facility, long-term care hospital, or rehab facility), ischemic complications (aphasia (ICD-9 diagnostic code 784. 
Statistics
Data were extracted from the Perspective database using SAS (version 9.3; SAS Institute, Inc., Cary, NC) and analyzed using JMP (version 9, SAS Institute) and R (version 2.15, R Foundation for Statistical Computing, Vienna, Austria). Continuous results are presented as median and interquartile range (IQR) to account for nonparametric data distributions. Categorical results are presented as relative frequencies (%). Patient, procedure, and hospital covariates and outcome incidences were compared between clipping and coiling groups using Wilcoxon rank-sum test for continuous variables and Fisher's exact test for categorical variables. Propensity score adjustment using 1:1 matching methods were performed using the MatchIt package in R. 
Propensity Score Analysis
Propensity score analysis was performed as previously described. 10 Propensity scores, representing the probability of receiving clipping treatment, were calculated for each patient in the clipping and coiling groups using a logistic regression model. Twenty-seven covariates were used to generate this propensity score, including patient variables (age, sex, race, admission status, admission source, priority of unruptured aneurysm diagnosis, Charlson comorbidity score [calculated from ICD-9 diagnostic codes as previously described], 11 and payor source), clipping/coiling procedure variables (priority of procedure and day of procedure), and hospital variables (region, number of beds, urban or rural location, and teaching or nonteaching status). After propensity score generation, clipping and coiling patients underwent 1:1 nearest neighbor (Greedy-type) matching of the logit of the propensity score with a caliper width of 0.25. Matching was performed without replacement and unpaired treated and control patients not meeting matching criteria were excluded. Each propensity score-derived matched pair was assigned a unique pair ID using an R script. Improvement in covariate balance after matching was determined using conditional logistic regression, conditioned on the pair ID. Odds ratios of primary and secondary outcomes were calculated after matching using Fisher's exact test.
Sensitivity Analysis
Sensitivity analysis was performed as described by Lin et al 12 to assess whether observed differences in outcomes between clipping and coiling groups could be completely attributed to an unmeasured confounder. The lower 95% confidence interval (CI) of the odds ratio (OR) of the primary outcome that was the closest to equivalency (1.00) when comparing clipping and coiling groups was used for this analysis. Hemorrhagic complications were chosen for sensitivity analysis because the lower 95% CI (1.33) was closest to equivalency of all primary outcomes significantly different between clipping and coiling groups.
Results
Patient Demographics
Between 2006 and 2011, 4899 patients from 120 unique medical facilities were hospitalized with ruptured aneurysms within the Perspective database. Within this patient population, 1388 patients (28%) underwent clipping and 3551 patients (72%) underwent coiling (Table 1 ). Significant differences between 
Temporal Trends in Clipping Versus Coiling
Propensity Score Adjusted Characteristics
The distribution of unmatched propensity scores for the clipping and coiling groups is shown in Figure 2 . Propensity score distributions were very similar between clipping and coiling groups. Following 1:1 matching, 1386 clipping and 1386 coiling patients were matched based on similarities in their demographic and clinical characteristics ( Table 2) . Following matching, all covariates were statistically indistinguishable between the clipping and coiling groups.
Propensity Score Adjusted Outcomes
Propensity score adjusted outcome incidence rates and odds ratios are shown in Table 3 . 
Sensitivity Analysis
Because the Perspective database lacks information on the size and location of cerebral aneurysms, we examined how such an unmeasured potential confounder could affect our findings using a sensitivity analysis. The sensitivity analysis, shown in Figure 3 , examines the relationship between confounder prevalence in the clipping and coiling groups and the odds ratio of the confounder with respect to hemorrhagic complications. For example, if the prevalence of an unmeasured confounder in the clipping group was 22% (dashed vertical line) and 5% in the coiling group (light grey curve), the odds ratio of the confounder would need to be ≈3.2 (point A) or higher to account for the significant differences observed in hemorrhagic complications. If the prevalence of the confounder increased to 10% in the coiling group (darker grey curve), the odds ratio would need to be even greater (5.0, point B) to account for the observed significant difference. Given that the incidence of large aneurysms (>13 mm) treated by clipping and coiling is reported to be 22% and 42%, respectively, 13 the odds ratio required to nullify the observed differences in hemorrhagic complications approaches infinity because of the asymptotic nature of this function. Given these results, the other measured outcomes would not be affected by treatment disparities in aneurysm size and would be unlikely to be affected by other unmeasured confounders.
Discussion
In this study of patients undergoing endovascular therapy for unruptured cerebral aneurysms from a large sample of US hospitals, patients treated with surgical clipping are at similar risk of in-hospital mortality but significantly greater risk of adverse outcomes than patients treated with endovascular coiling. Clipping recipients were more likely to be discharged to long-term care and were more likely to have periprocedural complications compared with coiling recipients. The relative merits of endovascular therapy versus open surgery or observation cannot be ascertained for individual cases in the Perspective database. Therefore, these findings do not indicate that all clipping recipients should have been offered coiling, because coiling would likely have been an inappropriate option for many of these patients. However, our study offers persuasive evidence that surgical clipping continues to be performed at a higher periprocedural risk of morbidity than coiling for a large number of patients in the United States.
Our findings corroborate other retrospective studies of large patient databases that also demonstrated a higher risk of mortality or morbidity after clipping as compared with coiling. [3] [4] [5] [6] [7] However, our study offers substantial advances compared with these previous studies. First, we performed propensity score adjustment using numerous patient and hospital covariates to better match clipping and coiling patients and minimize selection bias, and we performed a sensitivity analysis to measure the effect of a possible unmeasured confounder. These findings suggest that selection bias, if present, does not account for the observed differences in outcomes between coiling and clipping therapies. Second, the Perspective database enabled identification of clipping and coiling patients through billing information instead of ICD-9 procedural codes. Billing information has the advantage of greater specificity for cerebral coiling procedures, particularly before the creation of specific coiling ICD-9 codes in 2009, because earlier coiling procedures were routinely grouped into nonspecific ICD-9 procedural codes. Finally, the Perspective database contains hospitalizations through 2011, enabling an examination of more current clinical practice trends and outcomes compared to these previous studies.
Published guidelines for the treatment of unruptured cerebral aneurysms recommend that "microsurgical clipping rather than endovascular coiling should be the first treatment choice in low-risk cases." 14 Presumably, all patients treated with clipping in the Perspective database were offered clipping because the treating surgeon thought that it was a reasonably low-risk procedure relative to coiling. The outcomes in the Perspective database, however, suggest that the periprocedural risk is significantly higher than for coiling. A recent literature review found that retrospective in-hospital morbidity and mortality reported by single centers was reported to be an average of 7.9% for clipping and 8.1% for coiling. 15 Following propensity score matching of patients with similar demographic and clinical characteristics, our current study shows a much higher morbidity and mortality for clipping patients compared to these single center studies. This difference could be attributable in part to publication bias, where centers with better results are more likely to publish their findings. It is also possible that single center series are less accurate than an administrative database in reporting their own outcomes, a phenomenon demonstrated in the carotid endarterectomy literature where adverse event rates are significantly lower when assessed by the treating surgeon than when assessed by a neurologist. 16, 17 Overall use of clipping as compared with coiling of unruptured aneurysms has shown a steady decline from 2008 to 2011. The fraction of unruptured aneurysms treated by coiling in the Nationwide Inpatient Sample (NIS) increased from 11% in 1998 18 to 55.8% in 2007. 6 As coiling has become more refined as a therapy, it is reasonable to expect that treating centers are becoming more practiced at recognizing patients who can be expected to have a good outcome with coiling. Previously published studies of the NIS spanning 2001 to 2008 showed that centers that preferentially offered coiling compared with clipping had better outcomes than those that preferentially offered clipping. 19 Results from the International Study of Unruptured Intracranial Aneurysms (ISUIA) study, which included neurophysiological outcomes, also showed lower complication rates among patients treated with endovascular coiling compared with those treated with surgical clipping. 13 Size and location of an intracranial aneurysm are key determinants in assessing the risk of future rupture according to the ISUIA trial 13 and a large study in Japan. 20 Based on these studied the risk of rupture of small (<7 mm) anterior circulation aneurysms is quite low, and for most patients would not justify the risks of treatment with clipping or coiling observed in our study. The American Heart Association's recommendations 21 state that treatment of small, unruptured cerebral aneurysms cannot generally be advocated. Information about location and size of aneurysms treated is not available in the Perspective database, so we cannot predict the relative risk of rupture according to the natural history data from literature. But the majority of unruptured aneurysms are <7 mm and located in the anterior circulation, 22 so it is reasonable to assume that a substantial portion of patients treated in the Perspective database population had small, anterior circulation aneurysms. Distribution of aneurysm location is certainly expected to differ in the clipping and coiling cohorts (for example, more basilar aneurysms in the coiling cohort and more middle cerebral artery aneurysms in the clipping cohort), and we cannot ascertain aneurysm size or location from this database. However, our sensitivity analysis suggests that a very powerful unmeasured confounder with relatively dissimilar prevalence rates between treatment groups would be necessary to account for the outcome differences observed in this study. Because such a powerful confounder is unlikely to exist in this dataset, the observed outcome differences are likely not affected by confounding bias.
Although long-term outcomes cannot be evaluated with the Perspective database, discharge status can serve as a reasonable surrogate. In the ISUIA 13 trial, morbidity and mortality at 30 days was 13.7% with surgery and 9.3% with endovascular therapy, and at 1 year it was 12.6% and 9.8%, respectively. It might be argued that the higher recurrence rate associated with coiling compared with clipping could result in hemorrhages or complications of retreatment that negate the better periprocedural outcome with coiling. However, the International Subarachnoid Aneurysm Trial (ISAT), 23 Cerebral Aneurysm Rerupture After Treatment (CARAT), 24, 25 and the Barrow Ruptured Aneurysm Trial (BRAT) 26 studies demonstrated only minimally elevated risks of rehemorrhage of ruptured aneurysms with coiling relative to clipping, and it is reasonable to expect that coiling offers a similar relative efficacy for preventing hemorrhage from unruptured aneurysms. Small differences in hemorrhage rates in the clipping and coiling cohorts over years are not likely to become so large as to overcome the relatively large differences in periprocedural morbidity.
Our study has several limitations. First, we recognize that coding errors undoubtedly occur and can affect the retrospective evaluation of an administrative database, but this limitation is no different than in other studies of cerebral aneurysms using such databases, and such errors are likely to be equally prevalent in the clipping and coiling groups. Second, because patients were not randomized to clipping or coiling in our retrospective study, selection bias may exist. Although propensity score adjustment of patient age, sex, comorbidities, admission status and source, and hospital variables minimized differences between the clipping and coiling patient groups, other unmeasured variables may have still contributed to selection bias. Our evaluation of the Perspective data are by no means a randomized study but rather a retrospective look at outcomes based on prevailing practices. Observational data from large clinical databases can complement the findings of prospective clinical trials, because the database may better reflect real-world practice. A randomized trial would be useful to definitively assess the efficacy of treatment of unruptured cerebral aneurysms. 27 
Conclusions
In patients treated at a large group of hospitals in the United States from 2006 to 2011, surgical clipping of unruptured intracranial aneurysms was associated with significantly greater morbidity risk than endovascular coiling.
Disclosures
None. Figure 3 . Sensitivity analysis of unmeasured confounders. Sensitivity analysis was performed using the lower 95% confidence interval of the odds ratio of hemorrhagic complications (1.33). The x axis represents the prevalence of an unmeasured confounder in the clipping group. The y axis represents the hypothetical odds ratio associated with this unmeasured confounder. The curved lines represent the required strength of unmeasured confounder (defined by odds ratio [s] ) that would be required to nullify the observed differences in hemorrhagic complications between treated groups at selected confounder prevalence rates within the coiling group (5, 10, 20, 30, and 40%). For a given prevalence within the coiling group, a single unmeasured confounder could potentially nullify significant differences in study outcomes if the data point representing associated odds ratio and clipping prevalence is on or above the depicted curve. Point A depicts an example of a confounder with a prevalence of 22% in the clipping group and 5% in the coiling group; in this case an odds ratio of ≈3.2 is needed to nullify the significant difference in hemorrhagic complications. If the prevalence of the same confounder increased to 10% in the coiling group, an odds ratio of ≈5.0 (Point B) would be needed to nullify the significant difference.
